Udo Koehler, Ph.D. Lab Director, MGZ Medical Genetics Center, Munich, Germany
“MGZ uses the MiSeq and NextSeq 500 Systems to run a large number of custom panels to identify variants associated with rare hereditary diseases.”
READ MORE
ANDREW FELLOWES, Ph.D., FHGSA, FFSc (RCPA) Scientist in Charge, Molecular Pathology Diagnostic Development, Department of Pathology, Peter MacCallum Cancer Centre
“MiSeq and TruSeq Custom Amplicon introduce huge advantages in simplifying and streamlining the workflow, enabling us to deliver results within a clinically relevant time frame.”
READ MORE
DAVID BUCK, Ph.D. Head of High-Throughout Genomics, Wellcome Trust Centre for Human Genetics, University of Oxford
“I think we can start referring to the data that's generated on MiSeq as the new gold standard.”
READ MORE
TIM STINEAR, Ph.D. Principal Research Fellow, Department of Microbiology and Immunology, University of Melbourne
“You are getting significantly more data and higher quality data from a MiSeq run.”
READ MORE
BRYAN PAEPER Research Consultant, Northwest Genomics Center, University of Washington
“MiSeq does exactly what it's supposed to. It works in the specified amount of time. It produces the specified data quality. I've actually been really impressed.”
READ MORE
JAMES HADFIELD Genomics Core Director, Cambridge Research Institute
“Quite simply, we'll be able to do projects that we would have held off doing in the past such as single-end, long-read sequencing, and method development.”
READ MORE
JACOB KITZMAN Doctoral Candidate, Department of Genome Sciences at University of Washington
“The MiSeq turnaround time is excellent and the throughput is high. It gives us confidence in whether our library is going to be good or not, saving us money and helping prioritize samples for the HiSeq.”
READ MORE
Norma Neff, Ph.D. DNA Sequencing Core Director
Stanford University Medical Center
“The data quality that we get off the NextSeq 500 system at 2 x 75 bp is exactly what we’re looking for in our studies.”
READ MORE
Raja Mugasimangalam, Ph.D. President, Founder and CEO of Genotypic Technology
“The faster sequencing speed of the NextSeq 500 system is enabling us to handle a higher workload.”
READ MORE